Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prophylactic Selective Lateral Neck Dissection in Patients With Papillary Thyroid Carcinoma

This study has been completed.
Sponsor:
Information provided by:
Pusan National University Hospital
ClinicalTrials.gov Identifier:
NCT01103557
First received: April 12, 2010
Last updated: April 13, 2010
Last verified: January 2010
  Purpose

The purpose of this study is to prospectively analyze the incidence of occult lateral neck metastasis (LNM) and to elucidate the factors that predict LNM in papillary thyroid carcinoma (PTC) with central neck metastasis (CNM) by performing prophylactic selective lateral neck dissection (SND).


Condition Intervention
Thyroid Neoplasm
Lymphatic Metastasis
Procedure: prophylactic selective lateral neck dissection

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: The Effectiveness of Prophylactic Selective Lateral Neck Dissection in Papillary Thyroid Carcinoma Patients With Central Neck Metastasis

Resource links provided by NLM:


Further study details as provided by Pusan National University Hospital:

Enrollment: 62
Intervention Details:
    Procedure: prophylactic selective lateral neck dissection
    Level II, III, IV lymph node dissection
Detailed Description:

The lymphatic drainage pattern of the thyroid is uniform and consistent, and therefore, metastatic patterns are relatively predictable. Initial nodal metastasis in PTC usually occurs in the paratracheal and pretracheal nodes in level VI of the central compartment of the ipsilateral neck and spreads to the lateral cervical lymph nodes. Macroscopic skip metastases to the lateral compartment of the neck in the absence of central disease are uncommon.

  Eligibility

Ages Eligible for Study:   20 Years to 76 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Papillary thyroid carcinoma with central neck metastasis
  • No evidence of lateral neck metastasis as determined by high-resolution neck ultrasonography and computed tomography

Exclusion Criteria:

  • History of previous thyroid operation
  • Isthmic thyroid lesion
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Yun-Sung Lim, Pusan National University Hospital
ClinicalTrials.gov Identifier: NCT01103557     History of Changes
Other Study ID Numbers: PTC_CND_LND
Study First Received: April 12, 2010
Last Updated: April 13, 2010
Health Authority: Korea: Institutional Review Board

Keywords provided by Pusan National University Hospital:
Papillary thyroid carcinoma with neck metastasis
neck dissection

Additional relevant MeSH terms:
Carcinoma
Lymphatic Metastasis
Neoplasm Metastasis
Thyroid Diseases
Thyroid Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Head and Neck Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Neoplastic Processes
Pathologic Processes

ClinicalTrials.gov processed this record on November 27, 2014